• Licensing agreement with Eli Lilly enables Sandoz to commercialize and distribute Cialis® in the Brazilian market

Sao Paulo, December 18, 2014 – Sandoz, the generics pharmaceutical division of Novartis, announces today that it is launching Tadalafil, a generic version of Cialis®, indicated to treat patients with erectile dysfunction. With the launch, Sandoz will be the first pharmaceutical company to market a generic version of Cialis® in Brazil.

Tadalafil is the result of a trade agreement with Eli Lilly Brazil®, which allows Sandoz to commercialize …